Psychogenics

PsychoGenics is a biotechnology company that specializes in the discovery and development of innovative treatments for central nervous system (CNS) disorders. They utilize proprietary technologies, including high-throughput behavioral testing and machine learning, to identify potential drug candidates. The company generates revenue through partnerships with pharmaceutical and biotech firms, offering preclinical services and collaborative research opportunities. Founded in 1999, PsychoGenics has a history of pioneering approaches to CNS drug discovery, making significant contributions to the field with its unique combination of biology and technology.

Recent Posts by Psychogenics

1-3 of 3